Ignite Creation Date:
2024-05-05 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00498654
Status:
COMPLETED
Last Update Posted:
2008-07-02
First Post:
2007-07-09
Brief Title:
Dose Ranging Study to Determine the Safety Reactogenicity and Immunogenicity of Typhoid Fever Vaccine Ty800 in Healthy Adult Subjects
Sponsor:
Avant Immunotherapeutics
Organization:
Avant Immunotherapeutics
Study Overview
Official Title:
A Randomized Double-Blind Multi-Center Placebo-Controlled Dose Ranging Study to Determine the Safety Reactogenicity and Immunogenicity of a Single Oral Dose Typhoid Fever Vaccine Ty800 in Healthy Adult Subjects
Status:
COMPLETED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this trial is to examine the safety and immunogenicity of Ty800 oral vaccine in healthy adult subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None